| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $29.7M | -11.1% |
| Cost of Revenue | $12.0M | -19.1% |
| Gross Profit | $17.7M | -4.6% |
| R&D Expense | $23.6M | -4.5% |
| SG&A Expense | $9.9M | -2.7% |
| Operating Income | -$15.8M | +3.3% |
| Pre-tax Income | -$15.6M | +4.9% |
| Income Tax | $372K | +926.7% |
| Net Income | -$16.0M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.2M | -26.4% |
| Accounts Receivable | $3.5M | -23.2% |
| Inventory | $6.4M | +37.8% |
| Current Assets | $41.9M | -23.4% |
| Total Assets | $59.9M | -21.7% |
| Current Liabilities | $7.2M | -18.7% |
| Total Liabilities | $8.5M | -29.0% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.8M | -21.8% |
| Capital Expenditures | $316K | -59.2% |
| Investing Cash Flow | $6.7M | +59.3% |
| Financing Cash Flow | $402K | -83.0% |
| Free Cash Flow | -$17.2M | -17.5% |
| +2.4% |
| EPS (Basic) | -$0.65 | +3.0% |
| EPS (Diluted) | -$0.65 | +3.0% |
| Stockholders' Equity |
| $51.4M |
| -20.3% |